RB

Rakesh Bansal

Director DIN 08600719
DIN 08600719 First appointment Jun 2007
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 2007
Shareholding value β€’β€’β€’β€’ Premium profile

About Rakesh Bansal

Data last updated:

Rakesh Bansal was a Director at Gangaram Balmukund Super Speciality Hosp Ital Private Limited (from 2007) and Director at Encosmic Pharma Private Limited (from 2019).

DIN 08600719
First Appointment 21 Jun 2007
Oldest Company Age 19 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Jun 20072007Strike Off
Encosmic Pharma Private Limited U74999CH2019PTC042763
Director01 Nov 20192019Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Gangaram Balmukund Super Speciality Hosp Ital Private Limited
Encosmic Pharma Private Limited
Premium access

Shareholding and investment profile for Rakesh Bansal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakesh Bansal

Rakesh Bansal was first appointed on 21 Jun 2007 as Director at Gangaram Balmukund Super Speciality Hosp Ital Private Limited. The most recent appointment on record is 01 Nov 2019 at Encosmic Pharma Private Limited.

Rakesh Bansal held 2 earlier board appointments: Gangaram Balmukund Super Speciality Hosp Ital Private Limited (Director, from 21 Jun 2007); Encosmic Pharma Private Limited (Director, from 01 Nov 2019).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available